Rituximab induces regression of hepatitis C virus-related membranoproliferative glomerulonephritis in a renal allograft.

Authors :: Bestard O
Cruzado JM
Ercilla G
Gomà M
Torras J
Serón D
Rama I
Ibernon M
Viñas O
Carrera M
Grinyó JM
Source :: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 2006 Aug; Vol. 21 (8), pp. 2320-4. Date of Electronic Publication: 2006 Jun 04.
Publication Year :: 2006

Subjects :: Antibodies, Monoclonal, Murine-Derived
Antigens, CD20 immunology
B-Lymphocyte Subsets drug effects
Capillaries chemistry
Complement C4b analysis
Contraindications
Cryoglobulinemia drug therapy
Cryoglobulinemia etiology
Fatty Liver complications
Female
Follow-Up Studies
Glomerulonephritis, Membranoproliferative etiology
Glomerulonephritis, Membranoproliferative surgery
Glomerulonephritis, Membranoproliferative therapy
Graft Survival
HLA Antigens immunology
Hepatitis C, Chronic immunology
Humans
Interferon-alpha
Lymphocyte Count
Middle Aged
Peptide Fragments analysis
Postoperative Complications etiology
Postoperative Complications immunology
Recurrence
Renal Dialysis
Reoperation
Rituximab
Transplantation, Homologous
Viral Load
Viremia immunology
Antibodies, Monoclonal therapeutic use
Glomerulonephritis, Membranoproliferative drug therapy
Hepatitis C, Chronic complications
Immunosuppressive Agents therapeutic use
Kidney Transplantation
Postoperative Complications drug therapy
Viremia complications

Language :: English
ISSN :: 0931-0509
Volume :: 21
Issue :: 8
Database :: MEDLINE
Journal :: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Publication Type :: Academic Journal
Accession number :: 16751656
Full Text :: https://doi.org/10.1093/ndt/gfl266

Full Text Access

Tools